期刊
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
卷 26, 期 3, 页码 691-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.idc.2012.06.002
关键词
Traveler's diarrhea; Enterotoxigenic Escherichia coli; Vaccination; Prophylaxis
资金
- Baxter
- Novartis
- GSK
- Pfizer
- Nestle
Travelers' diarrhea (TD) is the most important health issue among international travelers. In high risk areas, 50-90% of travelers may experience an episode of TD. The risk of acquiring TD is influenced by factors such as the destination, duration of stay, standard of accommodation, type of travel, age of the traveler, and also by individual risk factors. Most cases of TD are caused by bacteria; treatment for TD are loperamide and antibiotics. Preventive strategies such as hygiene measures have limited impact. Prophylactic intake of antibiotics or vaccines to prevent from TD can be considered in special situations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据